🇺🇸 FDA
Patent

US 12269887

Anti-canine CD16 polypeptides, anti-canine CD64 polypeptides, compositions including same, and methods of using

granted A61KA61K2039/552

Quick answer

US patent 12269887 (Anti-canine CD16 polypeptides, anti-canine CD64 polypeptides, compositions including same, and methods of using) held by Regents of the University of Minnesota expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/552